AUGX
AUG Therapeutics
Phase 3
Estimated
AVTX-803 (L-Fucose)
Leukocyte Adhesion Deficiency
T-minus 146 days
Nov 30, 2026
ClinicalTrials.gov
verified 15h ago
Countdown card →